Published in

Public Library of Science, PLoS ONE, 2(13), p. e0191953, 2018

DOI: 10.1371/journal.pone.0191953

Links

Tools

Export citation

Search in Google Scholar

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes

Journal article published in 2018 by Åsa Ericsson ORCID, Divina Glah, Maria Lorenzi, Jeroen P. Jansen, Adam Fridhammar ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO